Answers are grounded in this paper and cite their sources.
MicroRNA-494 (miR-494) has emerged as a potential diagnostic biomarker for cancer detection, but conflicting reports have led to uncertainty regarding its clinical utility. This study aims to address these discrepancies by conducting a comprehensive meta-analysis of miR-494 diagnostic performance across various cancer types. A comprehensive literature search was performed across multiple databases, including PubMed, Web of Science, Wanfang databases, and CNKI (China National Knowledge Infrastructure), with a cutoff date of April 23, 2024. Eligible studies were identified using predefined inclusion criteria and various search strategies to ensure a thorough coverage of the available evidence. To evaluate the diagnostic performance of miR-494 in cancer detection, relevant measures such as sensitivity, specificity, and other diagnostic accuracy indicators were extracted from the included studies. These data were synthesized using bivariate meta-analysis models to generate pooled estimates of miR-494 diagnostic performance. All statistical analyses were conducted using the STATA 16.0 software. This meta-analysis pooled data from 8 studies, comprising a total of 647 cancer cases and 407 healthy controls. The aggregated diagnostic performance of miR-494 was as follows: a sensitivity of 0.67 (95% confidence interval [CI], 0.52–0.80), a specificity of 0.85 (95% CI, 0.77–0.91), and an area under the curve of 0.86 (95% CI, 0.82–0.88), indicating good overall diagnostic accuracy. The diagnostic odds ratio (DOR) was 12.11 (95% CI, 7–21), suggesting that miR-494 has strong discriminatory power in distinguishing cancer patients from healthy individuals. The positive likelihood ratio of 4.62 (95% CI, 3.1–6.8) and negative likelihood ratio of 0.38 (95% CI, 0.26–0.56) further support the diagnostic utility of miR-494. Deeks’ funnel plot asymmetry test was employed to assess potential publication bias, yielding a P value of 0.50, which suggests the absence of significant bias in the included studies. The meta-analysis results suggest that miR-494 exhibits promising diagnostic performance in detecting cancer, with moderate accuracy. The pooled sensitivity, specificity, and high area under the receiver operating characteristic curve highlight its potential as a cancer biomarker, indicating its utility in early detection and accurate diagnosis.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: